Home > Healthcare > Biotechnology > Bioservices > Single-use Bioreactors Market
Single-Use Bioreactors Market size was valued at USD 2.1 billion in 2022 and is estimated to account for USD 9.2 billion by 2032. Single-use bioreactors are also known as disposable bioreactors, in which disposable bag is used instead of a culture vessel. Processors can use disposable technologies, such as single-use bags, in the manufacturing process stage using single-use bioreactors.
This product of bioreactor is inexpensive and is primarily used for research. Rising prevalence regarding chronic disorders and severe infections will drive the demand for biopharmaceutical products. As per the Centers for Disease Control and Prevention (CDC), chronic disorders are among the leading causes of deaths in the U.S. Six out of ten people in the country suffer from a chronic disease.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Single-use Bioreactors Market Size in 2022: | USD 2.1 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 15.5 % |
2032 Value Projection: | USD 9.2 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 199 |
Tables, Charts & Figures: | 349 |
Segments covered: | Product, Cell, Molecule, Usage, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Rise in incidence of chronic conditions has enabled growth opportunities to the pharmaceutical market, especially for vaccines and therapeutics segments. Pharmaceutical manufacturers are adopting advanced bioreactor systems to enhance productivity. With escalating product demand, the companies are focusing on R&D for drug development and expanding manufacturing facilities that will positively influence the demand for single-use bioreactors.